- Home
- SXTP vs NCRA Comparison
SXTP vs NCRA Comparison
Compare SXTP & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | NCRA |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.1M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SXTP | NCRA |
|---|---|---|
| Price | $1.06 | $1.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | 78.3K | ★ 3.9M |
| Earning Date | 05-15-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,005,471.00 | ★ $13,627,944.00 |
| Revenue This Year | $33.92 | N/A |
| Revenue Next Year | $51.35 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 65.49 | N/A |
| 52 Week Low | $0.34 | $0.06 |
| 52 Week High | $8.62 | $3.98 |
Technical Indicators
Market Signals| Indicator | SXTP | NCRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 47.80 |
| Support Level | $1.05 | $0.18 |
| Resistance Level | $1.12 | $2.59 |
| Average True Range (ATR) | 0.09 | 0.21 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 24.00 | 3.85 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.